Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer To Become Largest Pharma In Japan After Wyeth Merger

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Pfizer Japan says upon Pfizer's expected merger with Wyeth later this year, it will become the largest pharmaceutical company in Japan, surpassing Takeda Pharmaceutical

You may also be interested in...



Despite A Wide Retreat From Discovery Research By Multinationals In Japan, Some Are Staying Put (Part 2 Of 3)

Countering the rush out of Japan's discovery research sector, a few global pharmaceutical corporations are maintaining early research operations or even expanding their presence in this area.

Despite A Wide Retreat From Discovery Research By Multinationals In Japan, Some Are Staying Put (Part 2 Of 3)

Countering the rush out of Japan's discovery research sector, a few global pharmaceutical corporations are maintaining early research operations or even expanding their presence in this area.

Pfizer/Wyeth Will Produce (Incremental) Growth, Pfizer Assures Investors

Pfizer management, more bullish than the Street on long-term revenue forecasts for the combination of Pfizer and Wyeth, assured investors that incremental growth opportunities will emerge from the mega merger during a follow-up meeting with investors Jan. 27

Related Content

UsernamePublicRestriction

Register

SC071018

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel